Literature DB >> 6832832

Response of human lymphocytes to measles virus after natural infection.

J I Greenstein, H F McFarland.   

Abstract

The lymphoproliferative response to measles, mumps, and vaccinia virus-infected monolayers measured in seropositive adults by thymidine incorporation demonstrated that only 5% of individuals responded well to measles virus (stimulation index, greater than 5). Possible explanations for this occurrence include a lack of sensitization, active suppression, or failure in long-term stimulation. To distinguish among these possibilities, we studied the responses to measles virus in 22 immunocompetent individuals during early convalescence from natural measles infection. Substantial responses occurred (stimulation index, 7.03), particularly in a smaller group which included those individuals with milder cases of the disease. The level of responsiveness declined over a period of weeks. Responder and nonresponder cell mixing showed no active cellular suppression. These studies indicate that the low responses to measles virus found in late convalescence represent a lack of prolonged stimulation of the cell population measured in this assay.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832832      PMCID: PMC264836          DOI: 10.1128/iai.40.1.198-204.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Cell-mediated immunity during natural measles infection.

Authors:  H C Whittle; J Dossetor; A Oduloju; A D Bryceson; B M Greenwood
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

2.  Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Fourth report to the medical research council by the measles sub-committee of the committee on development of vaccines and immunisation procedures.

Authors: 
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

3.  Evidence for a ninth influenza viral polypeptide.

Authors:  R A Lamb; P R Etkind; P W Choppin
Journal:  Virology       Date:  1978-11       Impact factor: 3.616

4.  Dissociation of lymphokine production and blastogenesis in children with measles infections.

Authors:  M I Joffe; A R Rabson
Journal:  Clin Immunol Immunopathol       Date:  1978-07

5.  Replication and persistence of measles virus in defined subpopulations of human leukocytes.

Authors:  B S Joseph; P W Lampert; M B Oldstone
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

6.  Quantitation of IgG, IgA and IgM in the CSF by radioimmunoassay.

Authors:  E S Mingioli; W Strober; W W Tourtellotte; J N Whitaker; D E McFarlin
Journal:  Neurology       Date:  1978-10       Impact factor: 9.910

7.  Cellular immune response to measles, mumps, and vaccinia viruses in multiple sclerosis.

Authors:  H F McFarland; D E McFarlin
Journal:  Ann Neurol       Date:  1979-08       Impact factor: 10.422

8.  Typical, modified, and atypical measles.

Authors:  R C Welliver; J D Cherry; A E Holtzman
Journal:  Arch Intern Med       Date:  1977-01

9.  Demonstration of HLA restricted killer cells in patients with acute measles.

Authors:  H W Kreth; V ter Meulen; G Eckert
Journal:  Med Microbiol Immunol       Date:  1979-01-24       Impact factor: 3.402

10.  Activation of measles virus from silently infected human lymphocytes.

Authors:  C J Lucas; J C Ubels-Postma; A Rezee; J M Galama
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  3 in total

1.  Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection.

Authors:  J Mongkolsapaya; A Jaye; M F Callan; A F Magnusen; A J McMichael; H C Whittle
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

2.  Biochemical and biological activities of recombinant S1 subunit of pertussis toxin.

Authors:  J T Barbieri; M Pizza; G Cortina; R Rappuoli
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

3.  Human cellular immune response to measles virus polypeptides.

Authors:  J W Rose; W J Bellini; D E McFarlin; H F McFarland
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.